Health News Roundup: US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea; China launches probe into surrogacy, fake paternity tests in Wuhan and more

The FDA said it had received reports of patients developing a type of T-cell blood cancer after being treated with genetically modified cells known as chimeric antigen receptor T-cell therapies or CAR-T. Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon Eleven people suffered bouts of dangerously low blood sugar in Lebanon this year, one of whom required hospitalization, after injecting suspected fake versions of Novo Nordisk's diabetes drug Ozempic, according Lebanese health officials.

Following is a summary of current health news briefs.

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Vivos Therapeutics said on Wednesday the U.S. health regulator has cleared its oral device treatment for severe obstructive sleep apnea (OSA).

China launches probe into surrogacy, fake paternity tests in Wuhan

Chinese authorities have suspended a hospital and a judicial institute in the city of Wuhan from conducting some services after they were accused of surrogacy and issuing fake paternity results. The suspension comes amid several investigations related to the issuance of fake birth certificates as China, where surrogacy is illegal, tries to boost its birth rate.

US FDA investigating safety risk of CAR-T cancer therapies

The U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating cancer therapies made by Gilead Sciences, Johnson & Johnson, Novartis and others over the risk of hospitalizations and death due to a serious safety issue. The FDA said it had received reports of patients developing a type of T-cell blood cancer after being treated with genetically modified cells known as chimeric antigen receptor T-cell therapies or CAR-T.

Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon

Eleven people suffered bouts of dangerously low blood sugar in Lebanon this year, one of whom required hospitalization, after injecting suspected fake versions of Novo Nordisk's diabetes drug Ozempic, according Lebanese health officials. A director for the Lebanese Ministry of Public Health, Rita Karam, said officials suspected the drugs were fake after discovering the doses were different from the ones calibrated for authentic Ozempic injector pens.

Biden campaign taps Pelosi on Obamacare after Trump threatens health law

President Joe Biden's re-election campaign enlisted former U.S. House Speaker Nancy Pelosi on Tuesday to warn about threats to the Affordable Care Act (ACA), better known as Obamacare, after former President Donald Trump pledged new efforts to replace the law if he wins a second term. THE TAKE: Tuesday's push, a Pelosi call with reporters and campaign staff, highlights a new Biden campaign strategy, dubbed "Trump's America in 2025," which plans to highlight what Democrats think the Republican former president will do in office if elected, as well as his multiple legal troubles.

US life expectancy climbs in 2022 after COVID retreat

U.S. babies born in 2022 gained roughly a year in life expectancy compared with babies born a year earlier, federal data showed on Wednesday, marking progress after two consecutive years of declines largely due to the COVID-19 pandemic. Life expectancy at birth for 2022 newborns was 77.5 years, up from 76.4 in 2021 but still lower than the 78.8 years expected for those born in 2019, data from the U.S. Centers for Disease Control and Prevention (CDC) suggests.

AIDS response 'under threat' amid human rights backlash - UN

The global response to AIDS is "under threat" because of an unprecedented backlash against human rights that is stigmatizing the groups most at risk of HIV infection, the head of the United Nations AIDS programme has warned. Winnie Byanyima, executive director of UNAIDS, said countries where there are laws against LGBTQ people, or which criminalise sex work or personal drug use, are largely the places seeing a rise or plateau in new infections.

US FDA flags new problem with Philips machines, shares fall

Philips shares fell more than 6% on Wednesday after the U.S. Food and Drug Administration said it is alerting patients of a new safety issue with machines made by the group that are used for the treatment of obstructive sleep apnea. The Amsterdam-based healthcare technology company has been grappling with the fallout of a global recall in June 2021 of millions of respirators used to treat sleep apnea over worries that foam used in the machines could become toxic.

Disease could be bigger killer than bombs in Gaza - WHO

More people could die from disease than from bombings in the Gaza Strip if its health system is not repaired, a World Health Organization spokesperson said on Tuesday, warning of a surge in infectious diseases and diarrhoea in children. In figures deemed reliable by the United Nations, Gaza health authorities say more than 15,000 people have been confirmed killed in Israel's bombardment of the narrow enclave, around 40% of them children, with many more feared to be lost under rubble.

WHO authorizes emergency use of Novavax's updated COVID shot

Novavax's updated vaccine has been granted emergency-use authorization by the World Health Organization (WHO) for active immunization to prevent COVID-19 in individuals aged 12 and older, the company said on Tuesday. The updated Novavax shot, which was authorized in the U.S. last month, targets a descendant of the XBB lineage of the coronavirus that was globally predominant earlier this year.

(With inputs from agencies.)